REGENERON PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of REGN for the last quarter is 52.12 B MXN, and it's 10.65% lower compared to the previous quarter. The net income of Q1 24 is 11.97 B MXN.